Combining them aims to calm inflammatory activity while supporting repair of the lining, which is why the stack is described as dual-action rather than a single mechanism
Serious Gastrointestinal Risks: While it mentions "changes in digestion," it omits potential severe side effects such as pancreatitis, gallbladder disease, and the risk of bowel obstruction/ileus, which are recognized clinical risks
Table 1 Clinical characteristics of the study subjects
Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity
Everyone recovers at a different pace
Counsel patients regarding the potential risk for MTC with the use of RYBELSUS or OZEMPIC tablets and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)